GTM Diagnostic
A scored, evidence-based read on any software company's go-to-market.
Built for PE deal teams, boards, and CEOs who need a fast, honest answer on where GTM is working and where it is leaking value.
What it is
Eight dimensions of go-to-market health, each scored 1 to 5 with a confidence level, grounded in the same metric definitions published in the CACulator.io calculators. The output is a defensible position on each dimension, not a maturity model or a survey.
How it works
Two delivery modes: an outside-in version built entirely from public data, useful pre-LOI or before an engagement, and a full version with internal data access and team interviews.
Who it is for
PE deal teams
A structured GTM read for diligence and a working plan for the first 100 days of ownership.
Boards
An independent second opinion on go-to-market when the internal narrative and the numbers disagree.
CEOs and CROs
An honest baseline before a transformation, so the plan starts from where the company actually is.
Sample diagnostic
A recently carved-out restaurant software company
A real diagnostic built entirely from public sources: the scored framework, the metric analysis behind each score, and the resulting strategy with a sequenced 90-day plan. It shows exactly what the artifact looks like before you share a single internal number.
Score summary
2.1/5
- ICP clarity and segment focus2 out of 5
- Competitive differentiation2 out of 5
- Product completeness2 out of 5
- Revenue quality and mix2 out of 5
- Retention and installed-base health2 out of 5
- GTM engine1 out of 5
- Integration and ecosystem posture3 out of 5
- Team and operating capacity3 out of 5

About the author
Scored by an operator who sat in the seat.
Mike Dayton has spent 20+ years leading revenue organizations in B2B software as CRO, CSO, and GM at PE-backed, public, and founder-led companies, including carveout diligence, integration, and turnaround work. The diagnostic is the structured version of the read he runs in those roles.
Want this run on a company you own or are buying?
Retainer clients get early access to upcoming diagnostic tooling.